NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Clinical Trial of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-044)

Not Yet RecruitingPhase 1

Sponsor: Merck Sharp & Dohme LLC

Conditions: Healthy

Interventions: Enlicitide

The goal of this trial is to learn what happens to different formulations (types) of enlicitide in a healthy person's body over time. Researchers will compare the amount of enlicitide in a healthy person's body over time when different formulations are given on an empty stomach and after a high-fat meal.

Eligibility overview

Sex: ALL

Age: 19 Years to 55 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Is in good health
* Has a body-mass index (BMI) between ≥18.0 and ≤32.0 kg/m\^2

Exclusion Criteria:

* Has history of gastrointestional (GI) disease which might affect food and drug absorption or has had gastric bypass or similar surgery. Examples of GI disease include (but are not limited to) recurrent vomiting, inflammatory bowel disease, chronic intestinal disease accompanied by a disturbance in digestion and absorption, Roemheld's syndrome, and severe hernia
* Has a history of cancer (malignancy)
* Has positive results for human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg), or hepatitis C virus (HCV)
* Is lactose intolerant